| Volume: | 3,146,572 |
|---|---|
| Day's Low: | $54.28 |
| 52-wk Low: | $36.90 |
| Previous Close: | $54.55 |
| Dividend: | $0.00 |
| Market Cap: | 25,071,300 |
| Avg Volume: | 3,352,500 |
|---|---|
| Day's High: | $55.12 |
| 52-wk High: | $58.31 |
| Open Price: | $54.67 |
| Yield: | 0.00% |
| P/E (Forward): | 29.49 |
| 10:29 AM | 10/22/2009 | UPDATE: Celgene 3Q Beats Views; Raises 2009 Estimates |
| 8:53 AM | 10/22/2009 | UPDATE: BEFORE THE BELL -2: US HOT STOCKS TO WATCH |
| 8:22 AM | 10/22/2009 | Celgene 3Q Net Up 58%, Beats Views |
| 2:40 PM | 10/16/2009 | US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches |
| 11/20/2009 | You know it's coming. |
| 11/19/2009 | Options Pin Down Stock Prices |
| 11/19/2009 | These companies fill investors with gratitude. |
| 11/19/2009 | Rethink the way you invest in mutual funds. |
| 11/12/2009 | Branded-drug makers aren't playing fair. |
| 11/11/2009 | FTC Says It's Concerned by Drug Makers' Practices |
| 10/27/2009 | Celgene (CELG): Bet on biotech for 'offense and defense' |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.50 | 0.34 | 47.06 |
| EPS, GAAP | 0.46 | 0.29 | 58.62 |
| Consensus Estimate | 0.49 | 0.35 | 40.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.60 | 1.41 | 13.48 |
| EPS, GAAP | 0.83 | -3.25 | NA |
| Consensus Estimate | 1.68 | NA | NA |
| CELG | Industry Average | |
| P/E (TTM) | 65.72 | 134.80 |
| P/E (Forward) | 29.49 | -20.50 |
| PEG Ratio | 1.22 | -1.03 |
| Price/Sales | 9.96 | 5.11 |
| Beta | 0.46 | 0.42 |